New Treatment Approaches to Myasthenia Gravis
- 1 January 1990
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 39 (1) , 66-73
- https://doi.org/10.2165/00003495-199039010-00006
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- HLA-DQ BETA-CHAIN POLYMORPHISM LINKED TO MYASTHENIA GRAVISThe Lancet, 1986
- Diaphragmatic myasthenia in mother and childPostgraduate Medical Journal, 1985
- Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- THE EFFECT OF ANTI‐THYMOCYTE ANTISERUM IN PROGRESSIVE MY ASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1981
- Plasma pyridostigmine levels in myasthenia gravisNeurology, 1981
- CLINICAL, PATHOLOGICAL, HLA ANTIGEN AND IMMUNOLOGICAL EVIDENCE FOR DISEASE HETEROGENEITY IN MYASTHENIA GRAVISBrain, 1980
- Plasma pyridostigmine levels in patients with myasthenia gravisClinical Pharmacology & Therapeutics, 1977
- The Value of Thymectomy in Myasthenia GravisAnnals of Surgery, 1976
- Myasthenia gravis unmasked by antiarrhythmic agents.1976
- MYASTHENIA GRAVIS: A CLINICAL REVIEW OF EIGHTY-SEVEN CASES OBSERVED BETWEEN 1915 AND THE EARLY PART OF 1932.1937